Medium-chain acyl-CoA dehydrogenase deficiency in the neonatal period: a case report
Aleksandra Wądołowska1, Magdalena Alicja Suda-Całus1, Ewa Matylda Gulczyńska1
1<p>Department of Neonatology, Neonatal Intensive Care Unit and Neonatal Pathology, Polish Mother's <br>Memorial Hospital - Research Institute, Łódz, Poland</p>.
Abstract:
Medium-chain acyl-CoA dehydrogenase deficiency (MCADD) is the most prevalent inherited disorder of fatty acid metabolism. The symptoms of MCADD typically present in infancy and may lead to adverse outcomes for the newborn, requiring urgent medical intervention. This study aimed to describe the pathogenetic mechanism, clinical presentation, diagnosis, and treatment through a case study of a newborn diagnosed with MCADD.
Related Concept Videos
Inborn Errors of Metabolism
Lipid Catabolism
Loss of Carboxy Group as CO2: Decarboxylation of Malonic Acid Derivatives
Diabetic Ketoacidosis ll: Pathophysiology
Acute Pancreatitis II: Pathophysiology
Diabetic Ketoacidosis l: Introduction


